Clinical trial

BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-

NCT00297063

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-11

PhasePHASE3

Study timeline

Study start (actual)2006-01-11Date precision: day

Registry last updated2022-11-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

RosiglitazoneDRUG · verified · RxNorm: rosiglitazone

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

TokyoJapan3 OsakaJapan1 FukuokaJapan1 KyotoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00297063 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.